Low STING expression on cancer cells correlated with shorter cancer-specific survival (CSS) in patients with CRC who underwent postoperative adjuvant chemotherapy (Fig. 1E and Table S1, log-rank p = 0.0411, n = 115). This evidence concerns the gene STING1 and colorectal carcinoma.